Catalyst Wire Dossier Catalyst Wire Dossier

hor se ATG

anti-thymocyte globulin (horse-derived) with cyclosporine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hor se ATG, covering 2017-02-23 to 2017-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment [Phase 2]

See pricing